Tag: respiratory syncytial virus



New RSV Drug Shows Positive Results

A phase 2a challenge study for GS-5806, an investigational oral RSV fusion inhibitor, found that the drug safely reduced the viral load and clinical illness of healthy adult volunteers who were intranasally infected with respiratory syncytial virus.

Sorry, No Posts Found